Facebook
Twitter
LinkedIn
ForwardClinical Updates in Allergy and Immunology 2025 - Livestream (virtual)
Course Directors - Rohit D. Divekar, M.B.B.S., Ph.D, Miguel A. Park, M.D., Gerald W. Volcheck, M.D.
July 31 - August 3, 2025 - Internet Live Activity - Dana Point, California
Mayo Clinic’s Clinical Updates in Allergy and Immunology 2025, held in Dana Point, California, and via livestream, aims to provide a contemporary understanding of allergic disorders with an emphasis on translating medical knowledge into clinical practice. The program offers a comprehensive multidisciplinary perspective on allergic disorders in a structured theme-based format. This year’s course focuses on food-related allergies and gastrointestinal conditions, in addition to common allergy disorders. Expert faculty from allergy, gastroenterology, and various other medical subspecialties present evidence-based and emerging clinical approaches to patient care.
| Early Bird Pricing | |
|---|---|
| Before March 15, 2025 | After March 14, 2025 |
| $749 | $849 |
Target Audience
This course is designed for allergists, internists, family medicine physicians, and pediatricians. Nurses, physician assistants, nurse practitioners and others involved in gastroenterology with a specific interest in allergy may also benefit from this course.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recognize the multidisciplinary intervention strategies for management of gastrointestinal related allergic disease including classical IgE mediated food allergy, non-IgE food allergy, eosinophilic esophagitis, celiac disease
- Recognize specific clinical features, diagnosis, and management of common allergic conditions including chronic urticaria
- Describe the indications and side effects of recent FDA approved medications in allergy
- Recognize specific clinical features, diagnosis, and management of common allergic conditions including anaphylaxis
- Recognize specific clinical features, diagnosis, and management of common allergic conditions including eosinophilic disorders
- Describe the indications and side effects of recent FDA approved medications in emerging therapeutics for management of allergic disease
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
All travel and lodging expenses are the sole responsibility of the individual registrant.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
AMA
This activity has been approved for AMA PRA Category 1 Credits™
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Price
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Equity, Diversity and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.